BRAF and melanoma: NF1 co-mutations with either BRAF or NRAS, as well as frequently with other melanoma-associated oncogenes, suggest that this is overall a weaker oncogenic driver that may cooperate with additional MAPK pathway alterations to drive melanomagenesis.